Sorry, the page you're looking for isn't here.

It may have been removed, had its name changed, or is temporarily unavailable.

Return to the Home Page

Use of Myrbetriq

MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Important Safety Information

Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.

MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ and go to the nearest hospital emergency room right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.

Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.

The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the
nose or throat (nasopharyngitis), urinary tract infection, and headache.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ® (mirabegron extended‑release tablets).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

You are now leaving myrbetriq.com

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Instagram.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Facebook.

You are now leaving myrbetriq.com. The third-party website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site. The third-party website is subject to its own Terms of Use and Privacy Policy. Astellas makes no representations as to the accuracy of the information contained on third-party websites. By clicking CONTINUE, you acknowledge that Astellas does not endorse or recommend any HCP associated with the third-party website, nor do we make any representations about the quality of medical care those professionals can provide. Astellas makes no guarantee that using the third-party website will result in the outcome you desire. The physician has no obligation to prescribe Myrbetriq and may instead prescribe another medication or no medication. It is wholly and solely your responsibility to assess the qualifications of a potential healthcare professional, and to discuss with them your symptoms as well as the risks and benefits of any potential treatment. You are responsible for any charges associated with services offered by the third-party website and should be aware that the third party may not accept medical insurance. ASTELLAS AND ITS AFFILIATES DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON INFORMATION PROVIDED TO YOU BY ANY HEALTHCARE PROFESSIONAL OR THE
THIRD-PARTY WEBSITE.

Note: The cost of a telehealth consultation is determined by and paid directly to the third-party telehealth company.

If you do not wish to leave Myrbetriq.com, click CANCEL, or click CONTINUE to go to the third-party website.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to FDA Medwatch.

The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site. Astellas makes no representation as to the accuracy of the information contained on third-party websites. By entering your postal code and clicking continue, you acknowledge that Astellas does not endorse or recommend any healthcare professional associated with the third-party website, nor does Astellas make any representations about the quality of medical care those healthcare professionals can provide.
Continue to WebMD.

Our Doctor Conversation Guide can help you start the overactive bladder conversation.

Show it to your doctor at your appointment!

Get your Doctor Conversation Guide